Lipidomics-Based Investigation of the Effects of Ginsenoside FI on Free Fatty Acid-Induced Metabolism in HepG2 Cells
Jie Zhou, Dai-Feng Su, Yu-Xin Chi, Quan-Cheng Chen, Yu-Xin Huang, Shu-Xian Chen, Shuang Liu, Jin-Hao Liu, Wei-Yun Zhang · 2026
Read Lipidomics-Based Investigation of the Effects of Ginsenoside FI on Free Fatty Acid-Induced Metabolism in HepG2 Cells by Jie Zhou, Dai-Feng Su, Yu-Xin Chi, Quan-Cheng Chen, Yu-Xin Huang, Shu-Xian Chen, Shuang Liu, Jin-Hao Liu, Wei-Yun Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13210415.txt.
Description
Jie Zhou and eight co-authors report a cell study on ginsenoside F1, a compound from ginseng, published in two thousand twenty-six. They asked how it affects fat handling in liver cells. The team grew HepG2 cells and loaded them with free fatty acids to mimic a fatty, high-lipid state. They then treated the cells with ginsenoside F1 at three doses. A statin drug served as the comparison.
Safe doses were picked first with a cell health test. Treated cells stored less fat than untreated model cells. Total cholesterol and triglyceride levels also fell. A broad lipid scan then mapped which lipids changed and which pathways they belong to. The work hints that the ginseng compound may help correct fat buildup in liver cells, though tests so far are only in the lab.
Catalog record
| CREATOR | Jie Zhou, Dai-Feng Su, Yu-Xin Chi, Quan-Cheng Chen, Yu-Xin Huang, Shu-Xian Chen, Shuang Liu, Jin-Hao Liu, Wei-Yun Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |